Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 13, 2020
Reporting Period: Fourth quarter and full year ended December 31, 2019.
Context: The filing serves to announce the issuance of a press release containing financial results for the specified period. The detailed results are furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The filing states that revenue, profit, cash flow, margins, debt, and liquidity figures are contained within the attached press release (Exhibit 99.1), which is not included in the input text. Therefore, no specific values for these metrics can be extracted from this document.
Material Changes
The filing text does not provide specific details regarding material changes in financial performance versus the prior comparable period. It only references the announcement of results for the fourth quarter and year ended December 31, 2019.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It strictly references the existence of a press release containing the results.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release) for actual revenue, net income, and cash flow figures for Q4 and FY 2019.
- Verify the company's liquidity position and debt levels as detailed in the full press release.
- Check for any year-over-year comparisons or management commentary on operational performance in the attached exhibit.
- Confirm the trading symbol (ACHV) and exchange (NASDAQ Capital Market) for current market data.